Full Text Journal Articles by
Author Jane J Kim

Advertisement

Find full text journal articles






Switching clinic-based cervical cancer screening programs to HPV self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women.

Kine Pedersen, Allison Portnoy, Stephen Sy, Bo T Hansen, Ameli Trope, Jane J Kim, Emily A Burger,

Several countries have implemented primary human papillomavirus (HPV) testing for cervical cancer screening. HPV testing enables home-based, self-collected sampling (self-sampling), which provides similar diagnostic accuracy as clinician-collected samples. We evaluated the impact and cost-effectiveness of switching an entire organized screening program to primary HPV self-sampling among cohorts of HPV vaccinated ... Read more >>

Int J Cancer (International journal of cancer)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard S Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar, Mona Saraiya, George F Sawaya, Nicolas Wentzensen, Mark Schiffman, ,

J Low Genit Tract Dis (Journal of lower genital tract disease)
[2021, 25(4):330-331]

Cited: 0 times

View full text PDF listing >>



Advertisement

Cost-effectiveness Analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Vidit N Munshi, Rebecca B Perkins, Stephen Sy, Jane J Kim,

<h4>Background</h4>Guidelines for managing abnormal cervical cancer screening tests changed from a results-based approach in 2012 to a risk-based approach in 2019. We estimated the cost-effectiveness and changes in resource utilization of the 2012 and 2019 guidelines.<h4>Methods</h4>We utilized a previously published model of cervical cancer natural history and screening to estimate ... Read more >>

Am J Obstet Gynecol (American journal of obstetrics and gynecology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation from a Statewide Registry.

Philip E Castle, Walter K Kinney, Lu Chen, Jane J Kim, Steven Jenison, Giovanna Rossi, Huining Kang, Jack Cuzick, Cosette M Wheeler, ,

In 2012, national recommendations for cervical-cancer screening of women aged 30-64 years were quinquennial human papillomavirus and cytology co-testing or triennial cytology. Data from a state-wide surveillance program in New Mexico demonstrated 65.2% (95% confidence interval [95%CI]= 64.6%% to 65.7%) of women screened in 2019 had negative co-test within the last ... Read more >>

J Natl Cancer Inst (Journal of the National Cancer Institute)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations.

Rebecca B Perkins, Rachael Adcock, Vicki Benard, Jack Cuzick, Alan Waxman, Jean Howe, Stephanie Melkonian, Janis Gonzales, Charles Wiggins, Cosette M Wheeler, ,

Failure to follow-up women after abnormal cervical screening could lead to cervical cancers, yet little is known about adherence to recommended follow-up after abnormal co-testing [cytology and high-risk human papillomavirus (hrHPV) testing]. We documented clinical management following cervical screening by co-testing in a diverse population-based setting. A statewide surveillance program ... Read more >>

Prev Med (Preventive medicine)
[2021, 153:106770]

Cited: 0 times

View full text PDF listing >>



Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.

Allison Portnoy, Kine Pedersen, Lill Trogstad, Bo T Hansen, Berit Feiring, Ida Laake, Megan A Smith, Stephen Sy, Mari Nygård, Jane J Kim, Emily A Burger,

Prev Med (Preventive medicine)
[2021, 150:106688]

Cited: 0 times

View full text PDF listing >>



Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.

Jack Cuzick, Ruofei Du, Rachael Adcock, Walter Kinney, Nancy Joste, Ruth M McDonald, Kevin English, Salina M Torres, Debbie Saslow, Cosette M Wheeler, ,

<h4>Objectives</h4>Human papillomavirus (HPV) testing for cervical screening has been shown to increase the yield of precancerous disease and reduce the incidence of cervical cancer more than cytology alone. Here we document the state-wide uptake of co-testing with HPV and cytology in women aged 30-64 years as recommended by national and international ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, 162(3):555-559]

Cited: 0 times

View full text PDF listing >>



Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India.

Jhanna Uy, Amita Girish Ketkar, Allison Portnoy, Jane J Kim,

<h4>Background</h4>Rheumatic mitral valve disease (RMVD) is a major cause of acquired valvular disease in India. We compared the cost-effectiveness of surgical treatment strategies for young adults with severe RMVD from an Indian public payer perspective.<h4>Methods</h4>We developed a Markov model to reflect the burden of RMVD among a hypothetical cohort of ... Read more >>

Int J Cardiol (International journal of cardiology)
[2021, 338:50-57]

Cited: 0 times

View full text PDF listing >>



Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns.

Allison Portnoy, Nicole G Campos, Stephen Sy, Emily A Burger, Jamie Cohen, Catherine Regan, Jane J Kim,

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2021, 30(6):1283]

Cited: 0 times

View full text PDF listing >>



Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study.

Allison Portnoy, Steven Sweet, Dawit Desalegn, Solomon Tessema Memirie, Jane J Kim, Stéphane Verguet,

High out-of-pocket (OOP) medical expenses for cervical cancer (CC) can lead to catastrophic health expenditures (CHEs) and medical impoverishment in many low-resource settings. There are 32 million women at risk for CC in Ethiopia, where CC screening is extremely limited. An evaluation of the population health and financial risk protection ... Read more >>

Health Policy Plan (Health policy and planning)
[2021, 36(6):891-899]

Cited: 0 times

View full text PDF listing >>



Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.

Megan A Smith, Emily A Burger, Alejandra Castanon, Inge M C M de Kok, Sharon J B Hanley, Matejka Rebolj, Michaela T Hall, Erik E L Jansen, James Killen, Xavier O'Farrell, Jane J Kim, Karen Canfell,

COVID-19 has disrupted cervical screening in several countries, due to a range of policy-, health-service and participant-related factors. Using three well-established models of cervical cancer natural history adapted to simulate screening across four countries, we compared the impact of a range of standardised screening disruption scenarios in four countries that ... Read more >>

Prev Med (Preventive medicine)
[2021, 151:106623]

Cited: 1 time

View full text PDF listing >>



Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta.

Nicole G Campos, Isabel C Scarinci, Laura Tucker, Sylvia Peral, Yufeng Li, Mary Caroline Regan, Stephen Sy, Philip E Castle, Jane J Kim,

<h4>Background</h4>African-American women in the United States have an elevated risk of cervical cancer incidence and mortality. In the Mississippi Delta, cervical cancer disparities are particularly stark.<h4>Methods</h4>We conducted a micro-costing study alongside a group randomized trial that evaluated the efficacy of a patient-centered approach ("Choice" between self-collection at home for HPV ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2021, 30(6):1114-1121]

Cited: 0 times

View full text PDF listing >>



Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

Emily A Burger, Erik El Jansen, James Killen, Inge McM de Kok, Megan A Smith, Stephen Sy, Niels Dunnewind, Nicole G Campos, Jennifer S Haas, Sarah Kobrin, Aruna Kamineni, Karen Canfell, Jane J Kim,

<h4>Objectives</h4>To quantify the secondary impacts of the COVID-19 pandemic disruptions to cervical cancer screening in the United States, stratified by step in the screening process and primary test modality, on cervical cancer burden.<h4>Methods</h4>We conducted a comparative model-based analysis using three independent NCI Cancer Intervention and Surveillance Modeling Network cervical models ... Read more >>

J Med Screen (Journal of medical screening)
[2021, 28(2):213-216]

Cited: 3 times

View full text PDF listing >>



Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.

Allison Portnoy, Kine Pedersen, Lill Trogstad, Bo T Hansen, Berit Feiring, Ida Laake, Megan A Smith, Stephen Sy, Mari Nygård, Jane J Kim, Emily A Burger,

Following the global call for action by the World Health Organization to eliminate cervical cancer (CC), we evaluated how each CC policy decision in Norway influenced the timing of CC elimination, and whether introducing nonavalent human papillomavirus (HPV) vaccine would accelerate elimination timing and be cost-effective. We used a multi-modeling ... Read more >>

Prev Med (Preventive medicine)
[2021, 144:106276]

Cited: 0 times

View full text PDF listing >>



Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.

Jane J Kim, Kate T Simms, James Killen, Megan A Smith, Emily A Burger, Stephen Sy, Catherine Regan, Karen Canfell,

<h4>Background</h4>A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for women and men aged 30 to 45 years in the context of cervical cancer screening practice was evaluated to inform ... Read more >>

PLoS Med (PLoS medicine)
[2021, 18(3):e1003534]

Cited: 2 times

View full text PDF listing >>



A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.

Nicole G Campos, Maria Demarco, Laia Bruni, Kanan T Desai, Julia C Gage, Sally N Adebamowo, Silvia de Sanjose, Jane J Kim, Mark Schiffman,

Health decision models are the only available tools designed to consider the lifetime natural history of human papillomavirus (HPV) infection and pathogenesis of cervical cancer, and the estimated long-term impact of preventive interventions. Yet health decision modeling results are often considered a lesser form of scientific evidence due to the ... Read more >>

Prev Med (Preventive medicine)
[2021, 144:106438]

Cited: 1 time

View full text PDF listing >>



Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis

Kiesha Prem, Yoon Hong Choi, Élodie Bénard, Emily Burger, Liza Hadley Mmath, Jean-François Laprise, Catherine Regan, Mélanie Drolet, Stephen Sy, Kaja Abbas, Jane Kim, Marc Brisson, Mark Jit,

<h4>Summary</h4> <h4>Background</h4> To eliminate cervical cancer as a public health problem, WHO currently recommends routine vaccination of adolescent girls with two doses of the human papillomavirus (HPV) vaccine before sexual debut. However, many countries have yet to implement this because of financial or logistical barriers to delivering two doses outside ... Read more >>

()
[, :]

Cited: 0 times

View full text PDF listing >>



Establishing Regulation of a Dynamic Process by Ypt/Rab GTPases : A Case for Cisternal Progression.

Jane J Kim, Zanna Lipatova, Nava Segev,

The prevailing model for transport within the Golgi is cisternal maturation. This process can be viewed as switching of cisternal markers using live-cell microscopy in yeast cells since the Golgi cisternae are separated, as opposed to the stacked Golgi seen in other organisms. It is also possible to determine which ... Read more >>

Methods Mol Biol (Methods in molecular biology (Clifton, N.J.))
[2021, 2293:189-199]

Cited: 0 times

View full text PDF listing >>



Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.

Isabel C Scarinci, Yufeng Li, Laura Tucker, Nicole G Campos, Jane J Kim, Sylvia Peral, Philip E Castle,

The goals of this study were to: (1) evaluate adherence to cervical cancer screening using a patient-centered approach that provided a choice of self-sampling at home for human papillomavirus (HPV) testing or standard of care screening at the local health department ('Choice') versus only standard of care screening at the ... Read more >>

Prev Med (Preventive medicine)
[2021, 142:106358]

Cited: 1 time

View full text PDF listing >>



Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.

Sara Fogelberg, Mark S Clements, Kine Pedersen, Stephen Sy, Pär Sparén, Jane J Kim, Emily A Burger,

<h4>Background</h4>Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23-29 years and primary human papillomavirus (HPV) testing for women aged 30-64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention policies for unvaccinated women, we evaluated the cost-effectiveness of alternative ... Read more >>

PLoS One (PloS one)
[2020, 15(9):e0239611]

Cited: 0 times

View full text PDF listing >>



Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard L Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar, Mona Saraiya, George Sawaya, Nicolas Wentzensen, Mark Schiffman,

J Low Genit Tract Dis (Journal of lower genital tract disease)
[2020, 24(4):426]

Cited: 0 times

View full text PDF listing >>



Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.

Emily A Burger, Inge M C M de Kok, Emily Groene, James Killen, Karen Canfell, Shalini Kulasingam, Karen M Kuntz, Suzette Matthijsse, Catherine Regan, Kate T Simms, Megan A Smith, Stephen Sy, Fernando Alarid-Escudero, Vivek Vaidyanathan, Marjolein van Ballegooijen, Jane J Kim,

<h4>Background</h4>The natural history of human papillomavirus (HPV)-induced cervical cancer (CC) is not directly observable, yet the age of HPV acquisition and duration of preclinical disease (dwell time) influences the effectiveness of alternative preventive policies. We performed a Cancer Intervention and Surveillance Modeling Network (CISNET) comparative modeling analysis to characterize the ... Read more >>

J Natl Cancer Inst (Journal of the National Cancer Institute)
[2020, 112(9):955-963]

Cited: 11 times

View full text PDF listing >>



Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.

Emily A Burger, Allison Portnoy, Nicole G Campos, Stephen Sy, Catherine Regan, Jane J Kim,

The human papillomavirus (HPV) vaccines may provide some level of cross-protection against high-risk HPV genotypes not directly targeted by the vaccines. We evaluated the long-term health and economic impacts of routine HPV vaccination using either the nonavalent HPV vaccine or the bivalent HPV vaccine in the context of 48 Gavi-eligible ... Read more >>

Int J Cancer (International journal of cancer)
[2021, 148(4):932-940]

Cited: 3 times

View full text PDF listing >>



Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.

Elizabeth T H Fontham, Andrew M D Wolf, Timothy R Church, Ruth Etzioni, Christopher R Flowers, Abbe Herzig, Carmen E Guerra, Kevin C Oeffinger, Ya-Chen Tina Shih, Louise C Walter, Jane J Kim, Kimberly S Andrews, Carol E DeSantis, Stacey A Fedewa, Deana Manassaram-Baptiste, Debbie Saslow, Richard C Wender, Robert A Smith,

The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV testing is not available, then individuals aged 25 to 65 years should be ... Read more >>

CA Cancer J Clin (CA: a cancer journal for clinicians)
[2020, 70(5):321-346]

Cited: 27 times

View full text PDF listing >>



Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.

Kate T Simms, Susan Yuill, James Killen, Megan A Smith, Shalini Kulasingam, Inge M C M de Kok, Marjolein van Ballegooijen, Emily A Burger, Catherine Regan, Jane J Kim, Karen Canfell,

<h4>Background</h4>SEER-reported cervical cancer incidence rates reflect the total female population including women no longer at risk due to hysterectomy. Hysterectomy rates have been declining in the United States as alternative treatments have become available, which could result in an apparent increase in SEER-reported cervical cancer rates. We aimed to obtain ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2020, 158(3):710-718]

Cited: 1 time

View full text PDF listing >>



Advertisement


Disclaimer

1.3161 s